Product Liability

Recalls a factor in CEO’s departure

An Associated Press story about the imminent retirement of longtime Johnson & Johnson CEO Bill Weldon mentions his company’s succession of product recalls over the last two years.

Weldon became the company’s CEO in 2002.

According to the story, there were more than two dozen recalls of nonprescription drugs and at least two for prescription drugs since 2009.

There were also recalls of about 25 medical devices and consumer products. Federal regulators have had three of the company’s factories under scrutiny, and shut ...

continue reading...

50,000 U.K. patients need yearly testing from hip implant

About 50,000 hip replacement patients in England and Wales will require annual medical tests to ensure that their metal-on-metal hip implants aren’t causing them potentially crippling complications, British newspaper The Independent reports.

That reflects the number of patients with large hip implants who will need annual blood tests to check their metal ion levels, including about 10,000 people with implants manufactured by DePuy, a subsidiary of Johnson & Johnson.

The risk with the metal-on-metal implants – which use a metal coating for ...

continue reading...

Medical groups voice concerns about transvaginal mesh implants

The American College of Obstetricians and Gynecologists and the American Urogynecologic Society recently issued a joint statement expressing the organizations’ concerns about the safety and effectiveness of transvaginal mesh implants to treat the condition pelvic organ prolapse.

In the statement, the groups say there’s an “urgent need” for a national registry to track outcomes for all current and future patients who get the procedure.

Pelvic organ prolapse occurs when there’s stretching or tearing of the pelvic floor muscles and connective tissue holding ...

continue reading...

Medical groups voice concerns about transvaginal mesh implants

The American College of Obstetricians and Gynecologists and the American Urogynecologic Society recently issued a joint statement expressing the organizations’ concerns about the safety and effectiveness of transvaginal mesh implants to treat the condition pelvic organ prolapse.

In the statement, the groups say there’s an “urgent need” for a national registry to track outcomes for all current and future patients who get the procedure.

Pelvic organ prolapse occurs when there’s stretching or tearing of the pelvic floor muscles and connective tissue holding ...

continue reading...

Yaz/Beyaz maker Bayer considering “significant” aquisition

Bayer, the German corporation that manufactures birth control pills Yaz, Beyaz and Yasmin, could finance a “significant” acquisition using a combination of debt, equity and its portfolio assets, Bloomberg reports.

Bloomberg cites an interview with Bayer’s Chief Financial Officer Werner Baumann, who said the company would only sell one of its three units “on the merits of its own strategic assessment.”

“You will not find us in a situation where we say we want to buy this, therefore we have to sell ...

continue reading...

British surgeons: Ban metal-on-metal hip joints

The British Hip Society, consisting of surgeons and scientists who work with the hip joint, has issued a recommendation that the use of metal-on-metal hip implants be discontinued because of their high early failure rate.

The Daily Telegraph quotes Joe Dias, president of the British Orthopaedic Association, as saying that about 5.5 percent of the large metal-on-metal implants – in which the ball and the socket are both coated with metal — needed to be replaced because of wear-and-tear within five ...

continue reading...
Page 120 of 132 «...90100110118119120121122...»